Valion Bio's filing says its press release highlighted new chair Thomas Jensen's expertise and goals. It reports no specific business change, so the news does not change the company's outlook.
This gives the company a new board leader, but the filing does not say what he plans to change. It reports no new business results, so the news alone does not change how Valion Bio's business looks.
Follow Valion Bio, Inc. (VBIO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for VBIO